• Profile
Close

The performance of glycated albumin as a biomarker of hyperglycemia and cardiometabolic risk in children and adolescents in the US

Pediatric Diabetes Nov 18, 2021

Wallace AS, Rooney MR, Brady TM, et al. - Among youth without diabetes, glycated albumin (GA: a non-fasting test) failed to detect those carrying a high cardiometabolic risk, and it does not seem to afford a suitable biomarker for screening of hyperglycemia.

  • In US youth, growing concerns include diabetes and prediabetes.

  • From the 1999–2004 National Health and Nutrition Examination Survey, a total of 6,826 youth without diabetes aged 8–19 years were cross-sectionally analyzed to assess the links of GA with HbA1c, fasting glucose (FG), and cardiometabolic risk factors.

  • A poor correlation of glycated albumin with HbA1c and FG was found, and GA was negatively related to BMI and cardiometabolic risk factors.

  • A higher prevalence of obesity (29.9% vs 7.6%), low high-density lipoprotein cholesterol (29.7% vs 16.5%), and hypertensive blood pressure (4.0% vs 2.7%) was observed in youth in the lowest GA tertile (<12.4%) vs those in the highest tertile (≥13.5%).

  • There was a poor correlation between glycated albumin and conventional markers of hyperglycemia in youth without diabetes.

  • Counterintuitively, a negative link was found between GA and BMI.

Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
  • Exclusive Write-ups & Webinars by KOLs

  • Nonloggedininfinity icon
    Daily Quiz by specialty
  • Nonloggedinlock icon
    Paid Market Research Surveys
  • Case discussions, News & Journals' summaries
Sign-up / Log In
x
M3 app logo
Choose easy access to M3 India from your mobile!


M3 instruc arrow
Add M3 India to your Home screen
Tap  Chrome menu  and select "Add to Home screen" to pin the M3 India App to your Home screen
Okay